These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 20350988)

  • 1. Early treatment with clarithromycin attenuates rat autoimmune myocarditis via inhibition of matrix metalloproteinase activity.
    Hishikari K; Watanabe R; Ogawa M; Suzuki J; Masumura M; Shimizu T; Takayama K; Hirata Y; Nagai R; Isobe M
    Heart; 2010 Apr; 96(7):523-7. PubMed ID: 20350988
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clarithromycin attenuates acute and chronic rejection via matrix metalloproteinase suppression in murine cardiac transplantation.
    Ogawa M; Suzuki J; Hishikari K; Takayama K; Tanaka H; Isobe M
    J Am Coll Cardiol; 2008 May; 51(20):1977-85. PubMed ID: 18482668
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clarithromycin attenuates myocardial ischemia-reperfusion injury.
    Nakajima T; Hishikari K; Ogawa M; Watanabe R; Suzuki J; Nagashima A; Masumura M; Takayama K; Hirata Y; Nagai R; Isobe M
    Expert Opin Ther Targets; 2010 Sep; 14(9):881-93. PubMed ID: 20662614
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effects of matrix metalloproteinase-9 inhibitor in Lewis rats with experimental autoimmune myocarditis].
    Han LN; Li TL; Zhang YJ; Yang TS; Ding Y; Zhao XN; Guo SL
    Zhonghua Xin Xue Guan Bing Za Zhi; 2011 Feb; 39(2):118-23. PubMed ID: 21426744
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Experimental study of MMP-2 inhibitor treatment of experimental autoimmune myocarditis in Lewis rats].
    Han LN; Li TL; Zhang YJ; Yang TS; Ding Y
    Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2011 Nov; 27(4):452-6. PubMed ID: 22295524
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunomodulation by interleukin-4 suppresses matrix metalloproteinases and improves cardiac function in murine myocarditis.
    Li J; Leschka S; Rutschow S; Schwimmbeck PL; Husmann L; Noutsias M; Westermann D; Poller W; Zeichhardt H; Klingel K; Tschope C; Schultheiss HP; Pauschinger M
    Eur J Pharmacol; 2007 Jan; 554(1):60-8. PubMed ID: 17113076
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Matrix metalloproteinase (MMP)-9, but not MMP-2, is involved in the development and progression of C protein-induced myocarditis and subsequent dilated cardiomyopathy.
    Matsumoto Y; Park IK; Kohyama K
    J Immunol; 2009 Oct; 183(7):4773-81. PubMed ID: 19734212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of early and late treatment with the tyrphostin AG-556 on the progression of experimental autoimmune myocarditis.
    George J; Barshack I; Goldberg I; Keren P; Gazit A; Levitzki A; Keren G; Roth A
    Exp Mol Pathol; 2004 Jun; 76(3):234-41. PubMed ID: 15126106
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Osteoprotegerin/RANK/RANKL axis in cardiac remodeling due to immuno-inflammatory myocardial disease.
    Liu W; Feng W; Wang F; Li W; Gao C; Zhou B; Ma M
    Exp Mol Pathol; 2008 Jun; 84(3):213-7. PubMed ID: 18417124
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of atorvastatin on the Th1/Th2 polarization of ongoing experimental autoimmune myocarditis in Lewis rats.
    Liu W; Li WM; Gao C; Sun NL
    J Autoimmun; 2005 Dec; 25(4):258-63. PubMed ID: 16242301
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Matrix metalloproteinase suppression induced by clarithromycin in murine cardiac allografts.
    Ogawa M; Suzuki J; Takayama K; Isobe M
    Transplant Proc; 2009; 41(1):395-7. PubMed ID: 19249565
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Ras antagonist farnesylthiosalicylic acid ameliorates experimental myocarditis in the rat.
    Pando R; Barshack I; Raz A; Luboshits G; Haklai R; Maysel-Auslender S; Kloog Y; Keren G; George J
    Cardiovasc Pathol; 2010; 19(2):94-101. PubMed ID: 19144546
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The anti-inflammatory mechanism of prostaglandin e2 receptor 4 activation in rat experimental autoimmune myocarditis.
    Ngoc PB; Suzuki J; Ogawa M; Hishikari K; Takayama K; Hirata Y; Nagai R; Isobe M
    J Cardiovasc Pharmacol; 2011 Mar; 57(3):365-72. PubMed ID: 21383594
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fusidin ameliorates experimental autoimmune myocarditis in rats by inhibiting TNF-alpha production.
    Milenkovć M; Arsenović-Ranin N; Vucićević D; Bufan B; Stojić-Vukanić Z
    Pharmazie; 2007 Jun; 62(6):445-8. PubMed ID: 17663192
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quercetin offers cardioprotection against progression of experimental autoimmune myocarditis by suppression of oxidative and endoplasmic reticulum stress via endothelin-1/MAPK signalling.
    Arumugam S; Thandavarayan RA; Arozal W; Sari FR; Giridharan VV; Soetikno V; Palaniyandi SS; Harima M; Suzuki K; Nagata M; Tagaki R; Kodama M; Watanabe K
    Free Radic Res; 2012 Feb; 46(2):154-63. PubMed ID: 22145946
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A cyclooxygenase-2 inhibitor alters Th1/Th2 cytokine balance and suppresses autoimmune myocarditis in rats.
    Suzuki J; Ogawa M; Futamatsu H; Kosuge H; Tanaka H; Isobe M
    J Mol Cell Cardiol; 2006 May; 40(5):688-95. PubMed ID: 16499924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of angiotensin-II receptor blockers on experimental autoimmune myocarditis.
    Liu X; Zhu X; Wang A; Fan H; Yuan H
    Int J Cardiol; 2009 Nov; 137(3):282-8. PubMed ID: 19896742
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HMG-CoA reductase inhibitor attenuates experimental autoimmune myocarditis through inhibition of T cell activation.
    Azuma RW; Suzuki J; Ogawa M; Futamatsu H; Koga N; Onai Y; Kosuge H; Isobe M
    Cardiovasc Res; 2004 Dec; 64(3):412-20. PubMed ID: 15537494
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardioprotective effects of recombinant human erythropoietin in rats with experimental autoimmune myocarditis.
    Mitsuma W; Ito M; Kodama M; Fuse K; Okamura K; Minagawa S; Kato K; Hanawa H; Toba K; Nakazawa M; Aizawa Y
    Biochem Biophys Res Commun; 2006 Jun; 344(3):987-94. PubMed ID: 16631620
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chymase inhibition reduces the progression to heart failure after autoimmune myocarditis in rats.
    Palaniyandi SS; Nagai Y; Watanabe K; Ma M; Veeraveedu PT; Prakash P; Kamal FA; Abe Y; Yamaguchi K; Tachikawa H; Kodama M; Aizawa Y
    Exp Biol Med (Maywood); 2007 Oct; 232(9):1213-21. PubMed ID: 17895529
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.